← back to search

Peter P. Ruvolo

The University of Texas MD Anderson Cancer Center · US
Area of research
Hematology · Molecular Biology
Research interest
Research interests include Acute Myeloid Leukemia Research, Protein Degradation and Inhibitors, Cell death mechanisms and regulation, and Chronic Myeloid Leukemia Treatments.
h-index
44
citations
8,646
works
226
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression
Oncotarget 2017cited by 8position: middledoi
Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers
Clinical Cancer Research 2016cited by 184position: middledoi
Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
Cancer Discovery 2013cited by 732position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Luca M. Neri · University of Ferrara1 papers (2017–2017)— · 1 papers (2017–2017)Linda S. Steelman · Sylvester Comprehensive Cancer Center1 papers (2017–2017)— · 1 papers (2017–2017)Vivian Ruvolo · The University of Texas MD Anderson Cancer Center1 papers (2017–2017)— · 1 papers (2017–2017)Lucio Cocco · Harvard Stem Cell Institute1 papers (2017–2017)James A. McCubrey · Northwell Health1 papers (2017–2017)— · 1 papers (2017–2017)Alberto M. Martelli · University of Ferrara1 papers (2017–2017)